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Poly (ADPribosyl) polymerase (PARP) is a 113 kD
nuclear protein. Following activation by DNA strand breaks,
PARP hydrolyzes NAD+ and catalyzes the formation of
poly(ADP-ribose) onto itself (automodification) and other
nuclear proteins (heteromodification) with the release of
nicotinamide. Poly(ADPribosyl)ation is an event of major
importance. It participates in fundamental processes such as
DNA repair, replication, cell cycle regulation and apoptosis
(d 'A m 0 u r s etai.1999).
PARP also participates in the regulation of transcription.
It appears to exert a dual function in this process: stimulation
and inhibition. In the absence of catalytic activity, PARP has
been shown to be a component of the pre-initiation
transcription complex. On the other hand, protein modification
with poly (ADPribose) is an efficient means of reversibly
silencing polymerase Il-dependent transcription (0 e i et al.
1998a). Consequently, the activating or repressing influence of
PARP on transcription depends on its catalytic activity. Poly
(ADPribosyl)ation occurs only if it is initiated before the
acceptor protein binds to DNA and thereby prevents the
formation of active transcription complexes. Otherwise, the
binding of the acceptor protein to DNA prevents its
modification. Recently, it was shown that the catalytically
active PARP moiety can cause silencing of transcription. It
modifies transcription factorsY'Yl (0 e i et al. 2001b), p53
(We s i e r s k a -Gad e k et ai. 19(6), TBP (0 e i et ai. 1998c)
and FOS (A m s tad et al. 1992) by poly (ADPribosyl) ation,
thereby interfering with their DNA-binding affinity.
PARP exists in a form that is associated with the nuclear
matrix (d' E r m e 1990). The nuclear matrix, the main
structural framework of the nucleus, is a nonhistone protein
scaffold that supports the attachment points of DNA loops
(B ere z n e y and Wei 1998;La e m m I i et ai. 1992). It is
now widely accepted that fundamental processes of the cell
nucleus are actively coordinated by the nuclear matrix. DNA
replication, transcription, mRNA processing and DNA repair
occur on the nuclear matrix (T u b 0 and B ere z n e y 1987).
Some of the protein components of the nuclear matrix appear
to be poly(ADPribosyl)ated (B err i 0 s et ai. 1985), whereas
others are tightly associated with PARP, suggesting a
modulatory role of the nuclear matrix-associated PARP in
nuclear functions.
In light of the potential role of PARP in certain nuclear
matrix-mediated functions, we examined the role of the
nuclear matrix-associated poly (ADPribosyl) ation system in
transcriptional regulation. The experimental model system of
7P
increased transcriptional activity of rat hepatocytes during the
acute-phase reaction (APR) was used.
Wistar strain male albino adult (2.5-month-old) rats
were used. The APR was induced (B a u man n et ai. 1984) by
subcutaneous injections of turpentine (~L1g body weight). The
animals were killed 24 h after the initial treatment when
hepatocyte transcriptional activity reaches its maximum
(S e val j e vic et al. 1982). Nuclear matrices were prepared
according to Bel g r a d e r et ai. (1991) from purified
hepatocyte nuclei (K auf man nand S hap e r 1984).
Nuclear and isolated nuclear matrix proteins were
electrophoresed under denaturing conditions (SDS-PAGE)
(L a e m m I i 1970). Immuno-blot analysis was performed
using a rabbit polyclonal antibody to rat PARP and C/EBP13,
and chemiluminescent staining (ECL) according to the
manufacturers instructions (Santa Cruz Biotechnology). A
PARP activity assay was performed with 200 ~M [l4C] NAD+.
One unit of PARP activity catalyzes the incorporation of 1
nmol of [14C] poly (ADPribose) into acid-insoluble material,
per minute, at 30°C. The in vitro poly (ADPribosyl) ation
reaction was performed according to Quesad a et ai. (1994).
Isolated hepatocyte nuclei were incubated with 0.2 ~M [32p]
NAD+ for 40 min at 20°C. The nuclear matrix was then
prepared from the incubated nuclei according to the described
procedure. Each labelled sample was subjected to SDS-PAGE,
run in duplicate and either stained with Coomassie brilliant
blue R-250 or subjected to Irnmuno-blot analysis.
The apparent tendency of PARP to associate with the nuclear
matrix was supported by irnmuno-blot analysis with anti-PARP
antibody. The control and APR-nuclei (Fig. 1, lanes 1 and 2,
respectively) and control (lane 3) and APR-nuclear matrices
(lane 4) possesed an intact form of PARP having a molecular
mass of 113 kD. Also, we concluded that the same relative
amount of PARP was present in the control (Fig. 1, lane 3) and
APR-matrices (lane 4). Neither the nuclease treatmentlh or
the high ionic strength extraction significantly affected the
solubility of nuclear PARP which partitioned with the nuclear
matrix of both control and APR samples. Earlier reports from
our laboratory showed that the bulk of nuclear transcription
factor C/EBP13 was complexed with the nuclear matrix. In the
nuclear extract preparation its relative concentration was
significantly lower (D i n i c et al. 2000). C/EBP13 isoforms (30,
35 and 38 kDa) were detected in control hepatocyte nuclei
(Fig. 1, lane 1) and nuclear matrices (lane 3). The stimulation
of haptoglobin gene transcription during the APR was
accompanied by increased concentrations in nuclei (lane 2)8P
kD
23% lower PARP activity observed in APR nuclei. Thus, we
concluded that the enzymatic activity of PARP was lower
during increased transcription.
Subsequently, control (lane 7) and APR nuclear matrices
(lane 8) were prepared from the in vitro poly (ADPribosyl)ated
nuclei. The anti-PARP antibody recognized in both control
and APR nuclear matrices qualitatively the same populations
of automodified and unmodified PARP proteins. Re-probing
of the same blot with anti-C1EBP~ antibody revealed that this
transcription factor was not modified. The antibody recognized
CIEBP~ isoforms at 38, 35 and 30 kDa positions in both the
control (lanes 5 and 7) and APR samples (lanes 6 and 8).
The overall decrease of PARP activity has an apparently
stimulatory effect on transcription. CIEBP~, an essential liver-
enriched transcription factor that plays a major role in the
transcriptional regulation of AP proteins (X anthop 0 u los
and M irk 0 vic h 1993), was not modified by PARP. It has
been shown that posttranslational phosphorylation /depho-
sphorylation of trans-factors modulates their activity during the
APR (R a y and Ray 1994). It appears that modification of
trans-factors by PARP does not playa role in the transcrip-
tional regulation of APR genes.
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and nuclear matrices (lane 4) of CIEBP~ which is involved
in the upregulation of several acute-phase protein genes.
During the APR we demonstrated an increased binding of
CIEBP~ to haptoglobin cIS-DNA (P 0 z nan 0 vicet al. 1999;
U s k 0 k 0 vicet al. 2002).
Fig. 1. Irnmuno-blot analysis with anti-PARP and anti-CIEBP[3
antibodies: lane 1 - control hepatocyte nuclei; lane 2 - APR-nuclei;
lane 3 - control nuclear matrix; lane 4 - APR-nuclear matrix.
Immuno-blot analysiswith anti-PARP and anti-CIEBP[3 antibodies
after in vitro poly (ADPribosyl)ation; lane 5 - the isolated control
hepatocyte nuclei after incubation with 0.2 /lM [32p] NAD+; lane
6 - APR-nuclei after incubation; lane 7 - the nuclear matrix
isolated from incubated control nuclei; lane 8 - the APR-nuclear
matrix isolated from APR-nuclei after incubation.
The catalytic activity of PARP during elevated
transcription in the course of the APR was compared with its
basal activity by a PARP activity assay. Isolated control and
APR hepatocyte nuclei were incubated with 200 uM [C14]
NAD+. The reaction was stopped and the radioactivity in the
acid-insoluble material counted. The enzyme activity of PARP
was 0.246 mU/mg protein and 0.190 mU/mg protein in the
control and APR nuclei, respectively. When its activity in the
control nuclei was normalized to 100%, then in the APR nuclei
it was 77%. We concluded that the enzymatic activity of PARP
was partially inhibited in the transcriptionally stimulated state
of hepatocyte nuclei.
Bearing in mind that the enzymatically active PARP
molecule could cause silencing of transcription by poly(ADP-
ribosyl)ation of transcription factors, we examined whether
CIEBP[3 was modified by PARP. Fig. 1 shows the results of
immune-blot analysis after in vitro poly (ADPribosyl) ation of
isolated nuclei. In both control andAPR nuclei, the anti-PARP
antibody revealed the presence of a heterogeneous popula-
tion of PARP molecules encompassing a broad spectrum
of automodified proteins. However, the unmodified (intact)
113 kD PARP detected in the APR nuclei was absent in the
control. These results are in agreement with the established
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